Skip to main content

Advertisement

Log in

Dynamic Changes of Matrix Metalloproteinase-9 in Patients with Klebsiella pneumoniae Meningitis

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

To quantitate cerebrospinal fluid (CSF) concentrations of matrix metalloproteinase 9 (MMP-9) in adult patients with Klebsiella pneumoniae meningitis and to correlate levels of MMP-9 with parameters of intrathecal inflammation and analyze the kinetic changes of MMP-9. In a prospective cohort study, levels of MMP-9 and tissue inhibitor of matrix metalloproteinase (TIMP-1) concentrations were measured in the CSF of six adult patients with meningitis and 11 controls. MMP-9 and TIMP-1 were detected in all of the six patients at presentation and follow up lumbar puncture. CSF levels of MMP-9 (6.71 ± 7.29 ng/ml) and TIMP-1(454.3 ± 242.9 ng/ml) were higher in patients than in the control group (0.07 ± 0.11 ng/ml and 27.14 ± 39.34 ng/ml, respectively). Levels of MMP-9 correlated with CSF concentrations of protein, cell count and lactate. Repeated lumbar punctures showed that levels of MMP-9 decrease during clinical recovery, although the levels of MMP-9 in the CSF are variable because of the small number of cases. The relative change in gelatin zymography is comparable to the changes of MMP-9 levels found in ELISA. MMP-9 levels in CSF may be a useful tool in follow-up in patients with K. pneumoniae meningitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Lu, C. H., W. N. Chang, and H. W. Chang. 2000. Adult bacterial meningitis in Southern Taiwan: epidemiologic trend and prognostic factors. J. Neurol. Sci. 182:36–44.

    Article  PubMed  CAS  Google Scholar 

  2. Tang, L. M., S. T. Chen, W. C. Hsu, and C. M. Chen. 1997. Klebsiella meningitis in Taiwan: an overview. Epidemiol. Infect. 119:135–142.

    Article  PubMed  CAS  Google Scholar 

  3. Lee, P. Y., W. N. Chang, C. H. Lu, M. W. Lin, B. C. Cheng, C. C. Chien, C. J. Chang, and H. W. Chang. 2003. Clinical features and in vitro antimicrobial susceptibilities of community-acquired Klebsiella pneumoniae meningitis in Taiwan. J. Antimicrob. Chemother. 51:957–62.

    Article  PubMed  CAS  Google Scholar 

  4. Lu, C. H., W. N. Chang, Y. C. Chuang, and H. W. Chang. 1998. The prognostic factors of adult gram-negative bacillary meningitis. J. Hosp. Infect. 40:27–34.

    Article  PubMed  CAS  Google Scholar 

  5. Tang, L. M., and S. T. Chen. 1994. Klebsiella pneumoniae meningitis: prognostic factors. Scand J Infect Dis. 26:95–102.

    Article  PubMed  CAS  Google Scholar 

  6. Pfister, H. W., and W. M. Scheld. 1997. Brain injury in bacterial meningitis: therapeutic implications. Curr. Opin. Neurol. 10:254–254.

    Article  PubMed  CAS  Google Scholar 

  7. Täuber, M. G., Y. S. Kim, and S. L. Leib. 1997. Neuronal injury in meningitis. In: In defense of the brain, Peterson, P. K., and J. S. Remington eds. Blackwell, Malden, MA, pp. 124–143.

    Google Scholar 

  8. Fang, C. T., Y. C. Chen, S. C. Chang, W. Y. Sau, and K. T. Luh. 2000. Klebsiella pneumoniae meningitis: timing of antimicrobial therapy and prognosis. QJM. 93:45–53.

    Article  PubMed  CAS  Google Scholar 

  9. Leppert, D., S. L. Leib, C. Grygar, K. M. Miller, U. B. Schaad, and G. A. Holländer. 2000. Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood–brain barrier damage and neurological sequelae. Clin. Infect. Dis. 31:80–84.

    Article  PubMed  CAS  Google Scholar 

  10. Yushchenko, M., F. Weber, M. Mäder, U. Schöll, M. Maliszewska, H. Tumani, K. Felgenhauer, and W. Beuche. 2000. Matrix metalloproteinase-9 (MMP-9) in human cerebrospinal fluid (CSF): elevated levels are primarily related to CSF cell count. J. Neuroimmunol. 110:244–251.

    Article  PubMed  CAS  Google Scholar 

  11. Yong, V. W., C. A. Krekoski, P. A. Forsyth, R. Bell, and D. R. Edwards. 1998. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci. 21:75–80.

    Article  PubMed  CAS  Google Scholar 

  12. Gottschall, P. E., and S. Deb. 1996. Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons. Neuroimmunomodulation. 3:69–75.

    Article  PubMed  CAS  Google Scholar 

  13. Apodaca, G., J. T. Rutka, K. Bouhana, M. E. Berens, J. R. Giblin, M. L. Rosenblum, J. H. McKerrow, and M. J. Banda. 1990. Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells. Cancer Res. 50:2322–2329.

    PubMed  CAS  Google Scholar 

  14. Uhm, J. H., N. P. Dooley, L. Y. Oh, and V. W. Yong. 1998. Oligodendrocytes utilize a matrix metalloproteinase, MMP-9, to extend processes along an astrocyte extracellular matrix. Glia. 22:53–63.

    Article  PubMed  CAS  Google Scholar 

  15. Leib, S. L., J. M. Clements, R. L. Lindberg, C. Heimgartner, J. M. Loeffler, L. A. Pfister, M. G. Tauber, and D. Leppert. 2001. Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis. Brain. 124:1734–1742.

    Article  PubMed  CAS  Google Scholar 

  16. Leib, S. L., Y. S. Kim, L. L. Chow, R. A. Sheldon, and M. G. Tauber. 1996. Reactive oxygen intermediates contribute to necrotic and apoptotic neuronal injury in an infant rat model of bacterial meningitis due to group B streptococci. J. Clin. Invest. 98:2632–2639.

    Article  PubMed  CAS  Google Scholar 

  17. Lee, H. C., Y. C. Chuang, W. L. Yu, N. Y. Lee, C. M. Chang, N. Y. Ko, L. R. Wang, and W. C. Ko. 2006. Clinical implications of hypermucoviscosity phenotype in Klebsiella pneumoniae isolates: association with invasive syndrome in patients with community-acquired bacteraemia. J. Intern, Med. 259:606–614.

    Article  CAS  Google Scholar 

  18. Nadasy, K. A., R. Domiati-Saad, and M. A. Tribble. 2007. Invasive Klebsiella pneumoniae syndrome in North America. Clin. Infect. Dis. 45:25–28.

    Article  Google Scholar 

  19. Fang, C. T., Y. P. Chuang, C. T. Shun, S. C. Chang, and J. T. Wang. 2004. A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications. J. Exp. Med. 199:697–705.

    Article  PubMed  CAS  Google Scholar 

  20. Nassif, X., N. Honore, T. Vasselon, S. T. Cole, and P. J. Sansonetti. 1989. Positive control of colanic acid synthesis in Escherichia coli by rmpA and rmpB, two virulence-plasmid genes of Klebsiella pneumoniae. Mol. Microbiol. 3:1349–1359.

    Article  PubMed  CAS  Google Scholar 

  21. Kolb, S. A., F. Lahrtz, R. Paul, D. Leppert, D. Nadal, H. W. Pfister, and A. Fontana. 1998. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: up-regulation of MMP-9 and TIMP-1 in cerebrospinal fluid. J. Neuroimmunol. 84:143–150.

    Article  PubMed  CAS  Google Scholar 

  22. Rosenberg, G. A., E. Y. Estrada, J. E. Dencoff, and W. G. Stetler-Stevenson. 1995. Tumor necrosis factor-α-induced gelatinase B causes delayed opening of the blood–brain barrier: an expanded therapeutic window. Brain Res. 703:151–155.

    Article  PubMed  CAS  Google Scholar 

  23. Yu, W. L., W. C. Ko, K. C. Cheng, H. C. Lee, D. S. Ke, C. C. Lee, C. P. Fung, and Y. C. Chuang. 2006. Association between rmpA and magA genes and clinical syndromes caused by Klebsiella pneumoniae in Taiwan. Clin. Infect. Dis. 42:1351–1358.

    Article  PubMed  CAS  Google Scholar 

  24. Ma, L. C., C. T. Fang, C. Z. Lee, C. T. Shun, and J. T. Wang. 2005. Genomic heterogeneity in Klebsiella pneumoniae strains is associated with primary pyogenic liver abscess and metastatic infection. J. Infect. Dis. 192:117–128.

    Article  PubMed  CAS  Google Scholar 

  25. Miller, A., S. Shapiro, N. Lahat, and Y. Galboiz. 2002. Matrix metalloproteinases and their inhibitors in brain injury and repair. In: Brain disease: therapeutic strategies and repair, Abramsky, O., D. A. S. Comspton, A. Miller, and G. Said eds. Martin Dunitz, UK, pp. 63–68.

    Google Scholar 

  26. Keiseier, B. C., T. Seifert, G. Giovannoni, and H. P. Hartung. 1999. Matrix metalloproteinases in inflammatory demyelination: targets for treatment. Neurology. 53:20–25.

    Article  Google Scholar 

  27. Harkness, K. A., P. Adamson, J. D. Sussman, G. A. Davies-Jones, J. Greenwood, and M. N. Woodroofe. 2000. Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium. Brain. 123:698–709.

    Article  PubMed  Google Scholar 

  28. Rosenberg, G. A., J. E. Dencoff, N. Correa Jr, M. Reiners, and C. C. Ford. 1996. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood–brain barrier injury. Neurology. 46:1626–1632.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work is supported by the Summer Medical Student Research Program 2007, from the Medical Foundation in Memory of Dr. Deh-Lin Cheng and also supported by grant VGHKS96-027 from Kaohsiung Veterans General Hospital, and grant NSC-96-2320-B-075B-002 from the National Science Council, Republic of China.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yao-Shen Chen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tsai, HC., Liu, SF., Wu, KS. et al. Dynamic Changes of Matrix Metalloproteinase-9 in Patients with Klebsiella pneumoniae Meningitis. Inflammation 31, 247–253 (2008). https://doi.org/10.1007/s10753-008-9071-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-008-9071-5

KEY WORDS

Navigation